Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4696232010 | Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4696233017 | Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Is a | Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some | ||
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has precise active ingredient | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has basis of strength substance (attribute) | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has precise active ingredient | Tenofovir disoproxil fumarate (substance) | true | Inferred relationship | Some | 2 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has basis of strength substance (attribute) | Tenofovir disoproxil (substance) | true | Inferred relationship | Some | 2 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR